1. Schneider AS, Valentine WN, Hattori M, Heins HL Jr. Hereditary hemolytic anemia with triosephosphate isomerase deficiency. N Engl J Med 1965; 272: 229-35.
2. Segal J, Mulleder M, Kruger A, et al. Low catalytic activity is insufficient to induce disease pathology in triosephosphate isomerase deficiency. J Inherit Metab Dis 2019; 42: 839–49
3. Aksu T. Hereditary red blood cell enzymopathies. J Pediatr Acad 2021; 2: 9-13.
4. Orosz F, Oláh J, Ovádi J. Triosephosphate isomerase deficiency: new insights into an enigmatic disease. Biochim Biophys Acta 2009; 1792: 1168-74.
5. Oliver C, Timson DJ. In silico prediction of the effects of mutations in the human triose phosphate isomerase gene: Towards a predictive framework for TPI deficiency. Eur J Med Genet 2017; 60: 289-98.
6. Linarello RE, Shetty AK, Thomas T, Warrier RP . Triosephosphate isomerase deficiency in a child with congenital hemolytic anemia and severe hypotonia. Pediatr Hematol Oncol 1998; 15: 553-6.
7. Valentin C, Pissard S, Martin J, et al. Triose phosphate isomerase deficiency in 3 French families: two novel null alleles, a frameshift mutation (TPI Alfortville) and an alteration in the initiation codon (TPI Paris). Blood 2000; 96: 1130-5.
8. Serdaroglu G, Aydinok Y, Yilmaz S, Manco L, Ozer E. Triosephosphate isomerase deficiency: a patient with Val231Met mutation. Pediatr Neurol 2011; 44: 139-42.
9. Pretsch W. Triosephosphate isomerase activity-deficient mice show haemolytic anaemia in homozygous condition. Genet Res (Camb) 2009; 91: 1-4.
10. Roland BP, Zeccola AM, Larsen SB, et al. Structural and genetic studies demonstrate neurologic dysfunction in triosephosphate isomerase deficiency is associated with impaired synaptic vesicle dynamics. PLoS Genet 2016; 12: e1005941.
11. Hrizo SL, Fisher IJ, Long DR, Hutton JA, Liu Z, Palladino MJ. Early mitochondrial dysfunction leads to altered redox chemistry underlying pathogenesis of TPI deficiency. Neurobiol Dis 2013; 54: 289-96.
12. Orosz F, Oláh J, Alvarez M, et al. Distinct behavior of mutant triosephosphate isomerase in hemolysate and in isolated form: molecular basis of enzyme deficiency. Blood 2001; 98: 3106-12.
13. Aissa K, Kamoun F, Sfaihi L, et al. Hemolytic anemia and progressive neurologic impairment: think about triosephosphate isomerase deficiency. Fetal Pediatr Pathol 2014; 33: 234-8.
14. Eber SW , Pekrun A, Bardosi A, et al. Triosephosphate isomerase deficiency: haemolytic anaemia, myopathy with altered mitochondria and mental retardation due to a new variant with accelerated enzyme catabolism and diminished specific activity. Eur J Pediatr 1991; 150: 761-6.
15. Yenicesu I, Kalayci O, Semizel E, et al. Triosephosphate isomerase deficiency with elevated sweat chloride test: report of a case. Turk J Pediatr 2000; 42: 319-21.
16. Conway AJ, Brown FC, Hortle EJ, et al. Bone marrow transplantation corrects haemolytic anaemia in a novel ENU mutagenesis mouse model of TPI deficiency. Dis Model Mech 2018; 11: dmm034678.
17. VanDemark AP, Hrizo SL, Eicher SL, et al. Itavastatin and resveratrol increase triosephosphate isomerase protein in a newly identified variant of TPI deficiency. Dis Model Mech 2022; 15: dmm049261.